Benitec Biopharma Ltd (BNTC)

[Blane]

I understand how you feel, however, ...


1. We are operating under strict inclusion/exclusion criteria for the trial.
2. Child bearing age women are excluded due to safety needing to be demonstrated in respect to affecting women's ova.
3. A few participants have lab values, namely aav8 antibodies, which for now is an exclusion criteria for allergic response purposes.
4. The first few cohorts are expected to take a less tha therapeutic dose, which may exclude them from future treatment with benitec's tech.
5. Only 2 trial sits have been opened, even though more are now expected to open. ( I presume this was done to try and see if they could save capital).

There may be a few other reasons. Based on this small list, I can totally understand why it is a little slow in getting patients dosed. We just need to be patient, and wait for efficacy levels, which hopefully will be this coming summer. I am personally hopeful that once that happens, things will start moving a little more quickly.